Partitioning of HIV-1 Gag and Gag-related proteins to membranes

被引:61
作者
Ehrlich, LS
Fong, S
Scarlata, S
Zybarth, G
Carter, C
机构
[1] SUNY STONY BROOK,DEPT MOLEC GENET & MICROBIOL,STONY BROOK,NY 11794
[2] SUNY STONY BROOK,DEPT PHYSIOL & BIOPHYS,STONY BROOK,NY 11794
关键词
D O I
10.1021/bi952337x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The binding of HIV-1 Gag and Gag-related proteins to model membranes was examined using three experimental systems: (i) large unilamellar phospholipid vesicles (LUVs) and recombinant Gag purified from Escherichia coli; (ii) LUVs added to a mammalian cell extract in which Gag proteins were expressed by a coupled transcription/translation system; and (iii) inside-out plasma membrane vesicles purified from human red blood cells (RBC) and recombinant, purified Gag from E. coli. Several novel aspects of HIV-1 Gag membrane interactions were observed: (i) Gag proteins bound with high affinity to both model membranes with a negatively charged surface and to RBC membranes. (ii) Binding of the Gag precursor and mature Gag proteins exhibited different sensitivities to ionic strength indicating that the precursor directed membrane binding through interactions that were qualitatively and quantitatively distinct from those of any of its individual domains. Studies using energy transfer between tryptophan residues in the proteins and anthroyloxy-containing probes inserted In the LUVs indicated that the orientation of the precursor and of the mature proteins on the membrane surface were distinct; (iii) Gag oligomers appear to have facilitated high-affinity binding under high salt conditions, suggesting that protein-protein interactions led to formation of stronger electrostatic or new hydrophobic membrane binding determinants. Since binding studies with model membranes permit quantitative analysis, these experimental approaches may permit identification of interactions that drive Gag assembly on the membrane.
引用
收藏
页码:3933 / 3943
页数:11
相关论文
共 46 条
[1]   LIPID-COMPOSITION AND FLUIDITY OF THE HUMAN-IMMUNODEFICIENCY-VIRUS ENVELOPE AND HOST-CELL PLASMA-MEMBRANES [J].
ALOIA, RC ;
TIAN, HR ;
JENSEN, FC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (11) :5181-5185
[2]   CELLULAR PROTEINS BOUND TO IMMUNODEFICIENCY VIRUSES - IMPLICATIONS FOR PATHOGENESIS AND VACCINES [J].
ARTHUR, LO ;
BESS, JW ;
SOWDER, RC ;
BENVENISTE, RE ;
MANN, DL ;
CHERMANN, JC ;
HENDERSON, LE .
SCIENCE, 1992, 258 (5090) :1935-1938
[3]   FUNCTIONAL CHIMERAS OF THE ROUS-SARCOMA VIRUS AND HUMAN-IMMUNODEFICIENCY-VIRUS GAG PROTEINS [J].
BENNETT, RP ;
NELLE, TD ;
WILLS, JW .
JOURNAL OF VIROLOGY, 1993, 67 (11) :6487-6498
[4]   SPECIFIC BINDING OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GAG POLYPROTEIN AND NUCLEOCAPSID PROTEIN TO VIRAL RNAS DETECTED BY RNA MOBILITY SHIFT ASSAYS [J].
BERKOWITZ, RD ;
LUBAN, J ;
GOFF, SP .
JOURNAL OF VIROLOGY, 1993, 67 (12) :7190-7200
[5]   MYRISTOYLATION-DEPENDENT REPLICATION AND ASSEMBLY OF HUMAN IMMUNODEFICIENCY VIRUS-1 [J].
BRYANT, M ;
RATNER, L .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (02) :523-527
[6]   A NUCLEAR-LOCALIZATION SIGNAL WITHIN HIV-1 MATRIX PROTEIN THAT GOVERNS INFECTION OF NONDIVIDING CELLS [J].
BUKRINSKY, MI ;
HAGGERTY, S ;
DEMPSEY, MP ;
SHAROVA, N ;
ADZHUBEI, A ;
SPITZ, L ;
LEWIS, P ;
GOLDFARB, D ;
EMERMAN, M ;
STEVENSON, M .
NATURE, 1993, 365 (6447) :666-669
[7]   HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 MA DELETION MUTANTS EXPRESSED IN BACULOVIRUS-INFECTED CELLS - CIS AND TRANS EFFECTS ON THE GAG PRECURSOR ASSEMBLY PATHWAY [J].
CHAZAL, N ;
GAY, B ;
CARRIERE, C ;
TOURNIER, J ;
BOULANGER, P .
JOURNAL OF VIROLOGY, 1995, 69 (01) :365-375
[8]   VIRAL-RNA ANNEALING ACTIVITIES OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 NUCLEOCAPSID PROTEIN REQUIRE ONLY PEPTIDE DOMAINS OUTSIDE THE ZINC FINGERS [J].
DEROCQUIGNY, H ;
GABUS, C ;
VINCENT, A ;
FOURNIEZALUSKI, MC ;
ROQUES, B ;
DARLIX, JL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (14) :6472-6476
[9]  
DICKSON C, 1985, MOL BIOL TUMOR VIRUS, P513
[10]   EXPRESSION IN ESCHERICHIA-COLI AND PURIFICATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 CAPSID PROTEIN (P24) [J].
EHRLICH, LS ;
KRAUSSLICH, HG ;
WIMMER, E ;
CARTER, CA .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1990, 6 (10) :1169-1175